Correlation Between Oric Pharmaceuticals and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Oric Pharmaceuticals and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oric Pharmaceuticals and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oric Pharmaceuticals and Cullinan Oncology LLC, you can compare the effects of market volatilities on Oric Pharmaceuticals and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oric Pharmaceuticals with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oric Pharmaceuticals and Cullinan Oncology.
Diversification Opportunities for Oric Pharmaceuticals and Cullinan Oncology
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Oric and Cullinan is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Oric Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oric Pharmaceuticals are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Oric Pharmaceuticals i.e., Oric Pharmaceuticals and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Oric Pharmaceuticals and Cullinan Oncology
Given the investment horizon of 90 days Oric Pharmaceuticals is expected to generate 1.31 times more return on investment than Cullinan Oncology. However, Oric Pharmaceuticals is 1.31 times more volatile than Cullinan Oncology LLC. It trades about -0.04 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.24 per unit of risk. If you would invest 856.00 in Oric Pharmaceuticals on September 18, 2024 and sell it today you would lose (32.00) from holding Oric Pharmaceuticals or give up 3.74% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Oric Pharmaceuticals vs. Cullinan Oncology LLC
Performance |
Timeline |
Oric Pharmaceuticals |
Cullinan Oncology LLC |
Oric Pharmaceuticals and Cullinan Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oric Pharmaceuticals and Cullinan Oncology
The main advantage of trading using opposite Oric Pharmaceuticals and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oric Pharmaceuticals position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.Oric Pharmaceuticals vs. Seer Inc | Oric Pharmaceuticals vs. Anebulo Pharmaceuticals | Oric Pharmaceuticals vs. Cullinan Oncology LLC | Oric Pharmaceuticals vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |